Bcr-Abl(Bcr-Abl酪氨酸激酶)
Bcl-Abl is a constitutively activated chimeric tyrosine kinase which is the genetic abnormality expressed in patient with CML (chronic myeloid leukemia).
Products for Bcr-Abl
- Cat.No. 产品名称 Information
-
GC10970
WP1130
A deubiquitinase inhibitor
-
GC14396
Ponatinib (AP24534)
An inhibitor of native and mutant Bcr-Abl
-
GC15197
Saracatinib (AZD0530)
A dual inhibitor of c-Src and Abl
-
GC11759
Imatinib Mesylate (STI571)
An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit
-
GC13343
Bosutinib (SKI-606)
An inhibitor of Src and Abl kinases
-
GC14129
Nilotinib(AMN-107)
A Bcr-Abl inhibitor
-
GC13102
XL228
A tyrosine kinase inhibitor
-
GC14237
Nilotinib monohydrochloride monohydrate
A Bcr-Abl inhibitor
-
GC10914
AST 487
A multi-kinase inhibitor
-
GC14592
KW 2449
A multi-kinase inhibitor
-
GC10638
AT9283
A broad spectrum kinase inhibitor
-
GC15568
Dasatinib (BMS-354825)
An inhibitor of Abl and Src
